Portal de Periódicos da CAPES

Diverse Applications of Nanomedicine

2017; American Chemical Society; Volume: 11; Issue: 3 Linguagem: Inglês

10.1021/acsnano.6b06040

1936-086X

Beatriz Pelaz, Christoph Alexiou, Ramón A. Álvarez‐Puebla, Frauke Alves, Anne M. Andrews, Sumaira Ashraf, Lajos Balogh, Laura Ballerini, Alessandra Bestetti, Cornelia Brendel, Susanna Bosi, Mónica Carril, Warren C. W. Chan, Chunying Chen, Xiaodong Chen, Xiaoyuan Chen, Zhen Cheng, Daxiang Cui, Jianzhong Du, Christian Dullin, Alberto Escudero, Neus Feliu, Mingyuan Gao, Michael George, Yury Gogotsi, Arnold Grünweller, Zhongwei Gu, Naomi J. Halas, Norbert Hampp, Roland K. Hartmann, Mark C. Hersam, Patrick Hunziker, Jian Ji, Xingyu Jiang, Philipp Jungebluth, Pranav Kadhiresan, Kazunori Kataoka, Ali Khademhosseini, Jindřich Kopeček, Nicholas A. Kotov, Harald F. Krug, Dong Soo Lee, Claus‐Michael Lehr, Kam W. Leong, Xing‐Jie Liang, Mei Ling Lim, Luis M. Liz‐Marzán, Xiaowei Ma, Paolo Macchiarini, Huan Meng, Helmuth Möhwald, Paul Mulvaney, André E. Nel, Shuming Nie, Peter Nordlander, Teruo Okano, J.P.R. de Oliveira, Tai Hyun Park, Reginald M. Penner, Maurizio Prato, Víctor Puntes, Vincent M. Rotello, Amila Samarakoon, Raymond E. Schaak, Youqing Shen, Sebastian Sjöqvist, André G. Skirtach, Mahmoud G. Soliman, Molly M. Stevens, Hsing‐Wen Sung, Ben Zhong Tang, Rainer Tietze, Buddhisha Udugama, J. Scott VanEpps, Tanja Weil, Paul S. Weiss, Itamar Willner, Yuzhou Wu, Lily Yang, Yue Zhao, Qian Zhang, Qiang Zhang, Xian‐En Zhang, Yuliang Zhao, Xin Zhou, Wolfgang J. Parak,

Nanoplatforms for cancer theranostics

The design and use of materials in the nanoscale size range for addressing medical and health-related issues continues to receive increasing interest. Research in nanomedicine spans a multitude of areas, including drug delivery, vaccine development, antibacterial, diagnosis and imaging tools, wearable devices, implants, high-throughput screening platforms, etc. using biological, nonbiological, biomimetic, or hybrid materials. Many of these developments are starting to be translated into viable clinical products. Here, we provide an overview of recent developments in nanomedicine and highlight the current challenges and upcoming opportunities for the field and translation to the clinic.